Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,812Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ZAKLADY FARMACEUTYCZNE POLPHARMA S A

02 1Aurobindo Pharma Limited

03 1Honour Lab Limited

04 1Jubilant Pharmova Limited

05 1MSN Life Sciences Private Limited

06 1OTSUKA PHARMACEUTICAL CO. LTD.

07 1ScinoPharm Taiwan Ltd.

08 1Sionc Pharmaceutical Private Limited

09 1Unichem Laboratories Limited, India

10 1Zhejiang Huahai Pharmaceutical Co., Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPolpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

BREXPIPRAZOLE

NDC Package Code : 12658-0501

Start Marketing Date : 2015-07-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Polpharma CB

02

The Generic Rx Session
Not Confirmed
arrow
arrow
The Generic Rx Session
Not Confirmed

BREXPIPRAZOLE

NDC Package Code : 59651-328

Start Marketing Date : 2023-12-14

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

03

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

BREXPIPRAZOLE

NDC Package Code : 69037-0035

Start Marketing Date : 2015-07-10

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

BREXPIPRAZOLE

NDC Package Code : 65372-1201

Start Marketing Date : 2018-12-31

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

BREXPIPRAZOLE

NDC Package Code : 46602-0001

Start Marketing Date : 2015-07-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

BioAsia
Not Confirmed
arrow

08

BioAsia
Not Confirmed
arrow

09

PharmScience R&D
Not Confirmed
arrow
arrow
PharmScience R&D
Not Confirmed

BREXPIPRAZOLE

NDC Package Code : 53747-084

Start Marketing Date : 2019-01-02

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

BioAsia
Not Confirmed
arrow

Looking for 913611-97-9 / Brexpiprazole API manufacturers, exporters & distributors?

Brexpiprazole manufacturers, exporters & distributors 1

95

PharmaCompass offers a list of Brexpiprazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brexpiprazole manufacturer or Brexpiprazole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brexpiprazole manufacturer or Brexpiprazole supplier.

PharmaCompass also assists you with knowing the Brexpiprazole API Price utilized in the formulation of products. Brexpiprazole API Price is not always fixed or binding as the Brexpiprazole Price is obtained through a variety of data sources. The Brexpiprazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Brexpiprazole

Synonyms

913611-97-9, Opc-34712, Rexulti, 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1h)-one, Opc 34712, 2j3ybm1k8c

Cas Number

913611-97-9

Unique Ingredient Identifier (UNII)

2J3YBM1K8C

About Brexpiprazole

Brexpiprazole is a novel D2 dopamine and serotonin 1A partial agonist, called serotonin-dopamine activity modulator (SDAM), and a potent antagonist of serotonin 2A receptors, noradrenergic alpha 1B and 2C receptors. Brexpiprazole is approved for the treatment of schizophrenia, and as an adjunctive treatment for major depressive disorder (MDD). Although it failed Phase II clinical trials for ADHD, it has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD).

Brexpiprazole Manufacturers

A Brexpiprazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brexpiprazole, including repackagers and relabelers. The FDA regulates Brexpiprazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brexpiprazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Brexpiprazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Brexpiprazole Suppliers

A Brexpiprazole supplier is an individual or a company that provides Brexpiprazole active pharmaceutical ingredient (API) or Brexpiprazole finished formulations upon request. The Brexpiprazole suppliers may include Brexpiprazole API manufacturers, exporters, distributors and traders.

click here to find a list of Brexpiprazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Brexpiprazole NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Brexpiprazole as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Brexpiprazole API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Brexpiprazole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Brexpiprazole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Brexpiprazole NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Brexpiprazole suppliers with NDC on PharmaCompass.

Brexpiprazole Manufacturers | Traders | Suppliers

Brexpiprazole Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.